Signature Resources Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
MCMU
Signature Resources Capital Management's RXRX Position: Q2 2026 in Review
Signature Resources Capital Management reduced its Recursion Pharmaceuticals (RXRX) stake by 93% in Q2 2026, selling an estimated $1.67K and leaving 38 shares worth $139. The position accounts for ﹤0.01% of the portfolio, ranked #684.
Signature Resources Capital Management first reported a position in RXRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.66K in Q1 2026. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.
- Signature Resources Capital Management held 38 shares of Recursion Pharmaceuticals worth $139 as of Q2 2026.
- Signature Resources Capital Management sold 501 Recursion Pharmaceuticals shares in Q2 2026, an estimated $1.67K.
- Recursion Pharmaceuticals made up ﹤0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #684 holding.
- Signature Resources Capital Management first reported a position in Recursion Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- Signature Resources Capital Management's Recursion Pharmaceuticals position peaked at $1.66K in Q1 2026.
- 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.
Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.